Evidence map›Paper›PMID 16983145›Full record

ArticleGenes & development2006

A cancer cell metalloprotease triad regulates the basement membrane transmigration program.

Kevin Hotary, Xiao-Yan Li, Edward Allen, Susan L Stevens, Stephen J Weiss

Erratum issuedAbstract read
In one paragraph

Article in Genes & development, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 187 papers.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

187 citing papers in PubMed.

  1. Review
  2. Article
  3. Integrin-Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. mCell & bioscience · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Cell-extracellular matrix dynamics.Physical biology · 2022
    Review
  16. Article
  17. Review
  18. Regulatory mechanism of oral mucosal rete peg formation.Journal of molecular histology · 2021
    Review
  19. Review
  20. Review

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors.

Kevin HotaryDivision of Molecular Medicine and Genetics, Department of Internal Medicine, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.
Xiao-Yan Li
Edward Allen
Susan L Stevens
Stephen J Weiss

Funding

FUNCTION OF THE MEMBRANE TYPE MATRIX METALLOPROTEINASER01CA071699 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEISS, STEPHEN J · 1997 to 2024
$7.3M
METALLOPROTEASE DEPENDENT FIBRINOLYSIS AND ANGIOGENESISR01CA088308 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEISS, STEPHEN J · 2000 to 2015
$4.6M
NCI NIH HHS R01 CA071699NCI NIH HHS R01 CA088308NCI NIH HHS R01 CA71699NCI NIH HHS R01 CA88308
6 · The paper itself

Abstract

Carcinoma cells initiate the metastatic cascade by inserting invasive pseudopodia through breaches in the basement membrane (BM), a specialized barrier of cross-linked, extracellular matrix macromolecules that underlies epithelial cells and ensheaths blood vessels. While BM invasion is the sine qua non of the malignant phenotype, the molecular programs that underlie this process remain undefined. To identify genes that direct BM remodeling and transmigration, we coupled high-resolution electron microscopy with an ex vivo model of invasion that phenocopies the major steps observed during the transition of carcinoma in situ to frank malignancy. Herein, a triad of membrane-anchored proteases, termed membrane type-1, type-2, and type-3 metalloproteinases, are identified as the triggering agents that independently confer cancer cells with the ability to proteolytically efface the BM scaffolding, initiate the assembly of invasive pseudopodia, and propagate transmigration. These studies characterize the first series of gene products capable of orchestrating the entire BM remodeling program that distinguishes the carcinomatous phenotype.

Indexed as

AnimalsBasement MembraneCell LineCell Line, TumorCell MovementChlorocebus aethiopsCollagen Type IVCOS CellsExtracellular MatrixHumansMatrix Metalloproteinase 14Matrix Metalloproteinase 15Matrix Metalloproteinase 16Matrix Metalloproteinases, Membrane-AssociatedMiceMicroscopy, Electron, ScanningCollagen Type IVMatrix Metalloproteinase 14Matrix Metalloproteinase 15Matrix Metalloproteinase 16Matrix Metalloproteinases, Membrane-AssociatedRNA, Small InterferingTissue Inhibitor of Metalloproteinases

Identifiers

PMID16983145
PMCPMC1578694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.